Blockade of mesolimbic dopamine D3 receptors inhibits stress-induced reinstatement of cocaine-seeking in rats

Psychopharmacology

Volumn 176, Issue 1, 2004, Pages 57-65

  Xi, Zheng Xiong ^a   Gilbert, Jeremy ^a   Campos, Arlene C ^a   Kline, Nicole ^a   Ashby Jr , Charles R ^b   Hagan, Jim J ^c   Heidbreder, Christian A ^d   Gardner, Eliot L ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b ST JOHN'S UNIVERSITY   (United States)

^c GLAXOSMITHKLINE   (United Kingdom)

^d GSK   (Italy)

Author keywords

Accumbens; Addiction; Cocaine; D3 antagonist; Dopamine; Reinstatement; Relapse; SB 277011A; Self administration; Stress

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; COCAINE; DOPAMINE 3 RECEPTOR BLOCKING AGENT; N [4 [2 (6 CYANO 1,2,3,4 TETRAHYDRO 2 ISOQUINOLINYL)ETHYL]CYCLOHEXYL] 4 QUINOLINECARBOXAMIDE; SODIUM CHLORIDE;

ARTICLE; BEHAVIOR; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DRUG SELECTIVITY; LIMBIC CORTEX; MALE; MICROINJECTION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; REINFORCEMENT; SHOCK;

ANIMALS; COCAINE; COCAINE-RELATED DISORDERS; CONDITIONING, OPERANT; CORPUS STRIATUM; EXTINCTION, PSYCHOLOGICAL; INFUSIONS, INTRAVENOUS; MALE; MICROINJECTIONS; NITRILES; NUCLEUS ACCUMBENS; RATS; RATS, LONG-EVANS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RECURRENCE; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION; STRESS, PSYCHOLOGICAL; SUBSTANCE WITHDRAWAL SYNDROME; TETRAHYDROISOQUINOLINES;

EID: 3242793884     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-004-1858-y     Document Type: Article

References (57)

1. 3 receptors prevents nicotine-triggered relapse to nicotine-seeking behavior. Neuropsychopharmacology 28:1272-1280
2. 3 receptor antagonist SB-277011-A blocks the acquisition and expression of the conditioned place preference response to heroin in male rats. Synapse 48:154-156
3. Austin NE, Baldwin SJ, Cutler L, Deeks N, Kelly PJ, Nash M, Shardlow CE, Stemp G, Thewlis K, Ayrton A, Jeffrey P (2001) Pharmacokinetics of the novel, high-affinity and selective dopamine D3 receptor antagonist SB-277011 in rat, dog and monkey: in vitro/in vivo correlation and the role of aldehyde oxidase. Xenobiotica 31:677-686
4. 2 receptor mRNA. Brain Res 564:203-219
5. 3 dopamine receptors. Science 260:1814-1816
6. Caine SB, Koob GF (1995) Pretreatment with the dopamine agonist 7-OH DPAT shifts the cocaine self-administration dose-effect function to the left under different schedules in the rat. Behav Pharmacol 6:333-347
7. 3 receptor test in vitro predicts decreased cocaine self-administration in rats. Neuroreport 8:2373-2377
8. 2 receptors. J Med Chem 46:3822-3839
9. Carter BL, Tiffany ST (1999) Meta-analysis of cue-reactivity in addiction research. Addiction 94:327-340
10. 9-tetrahydrocannabinol enhances ventral tegmental somatodendritic dopamine levels but not forebrain dopamine levels: evidence for local neural action by marijuana's psychoactive ingredient. Brain Res 621:65-70
11. Depoortere R, Perrault G, Sanger DJ (1999) Intracranial self-stimulation under a progressive-ratio schedule in rats: effects of strength of stimulation, d-amphetamine, 7-OH-DPAT and haloperidol. Psychopharmacology 142:221-229
12. 3 receptor in the rat brain. Neuroscience 65:731-745
13. 3 dopamine receptor antagonist SB-277011-A. Neuropsychopharmacology 28:329-338
14. Epstein DH, Preston KL (2003) The reinstatement model and relapse prevention: a clinical perspective. Psychopharmacology 168:31-41
15. Greengard P (2001) The neurobiology of dopamine signaling. Biosci Rep 21:247-269
16. Kalivas PW, Duffy P (1995) Selective activation of dopamine transmission in the shell of the nucleus accumbens by stress. Brain Res 675:325-328
17. Katz JL, Higgins ST (2003) The validity of the reinstatement model of craving and relapse to drug use. Psychopharmacology 168:21-30
18. 3 receptor agonist 7-OH-DPAT in rhesus monkeys trained to discriminate cocaine from saline. Psychopharmacology 124:306-314
19. 3 receptor sites in rat brain. A comparative study using in situ hybridization histochemistry and ligand binding autoradiography. Eur J Neurosci 5:145-153
20. Lavicky J, Dunn AJ (1993) Corticotropin-releasing factor stimulates catecholamine release in hypothalamus and prefrontal cortex in freely moving rats as assessed by microdialysis. J Neurochem 60:602-612
21. Leri F, Flores J, Rodaros D, Stewart J (2002) Blockade of stress-induced but not cocaine-induced reinstatement by infusion of noradrenergic antagonists into the bed nucleus of the stria terminalis or the central nucleus of the amygdala. J Neurosci 22:5713-5718
22. 3 dopamine receptor: neurobiology and potential clinical relevance. Pharmacol Rev 49:231-252
23. 3 receptor agents as potential new medications for drug addiction. Eur Psychiatry 15:140-146
24. Moghaddam B (2002) Stress activation of glutamate neurotransmission in the prefrontal cortex: implications for dopamine-associated psychiatric disorders. Biol Psychiatry 51:775-787
25. Nader MA, Mach RH (1996) Self-administration of the dopamine D3 agonist 7-OH-DPAT in rhesus monkeys is modified by prior cocaine exposure. Psychopharmacology 125:13-22
26. National Academy of Sciences (1996) Guide for the care and use of laboratory animals. National Academy, Washington, D.C.
27. Nestler EJ (2001) Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2:119-128
28. O'Brien CP (1997) A range of research-based pharmacotherapies for addiction. Science 278:66-70
29. 3 receptor stimulation enhances cocaine reinforcement. J Neurochem 67:1078-1089
30. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, 4th edn. Academic, San Diego
31. 3 receptor agonist. Nature 400:371-375
32. Platt DM, Rowlett JK, Spealman RD (2002) Behavioral effects of cocaine and dopaminergic strategies for preclinical medication development. Psychopharmacology 163:265-282
33. Preti A (2001) BP-897 bioproject. Curr Opin Invest Drugs 1:110-115
34. 3 receptor antagonist, SB-277011-A. J Pharmacol Exp Ther 294:1154-1165
35. Roberts DCS, Ranaldi R (1995) Effect of dopaminergic drugs on cocaine reinforcement. Clin Neuropharmacol 18:S84-S95
36. Rothman RB, Glowa JR (1995) A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development. Focus on GBR 12909. Mol Neurobiol 11:1-19
37. Schuckit MA (1994) The treatment of stimulant dependence. Addiction 89:1559-1563
38. Shaham Y, Miczek KA (2003) Reinstatement - toward a model of relapse. Psychopharmacology 168:1-2
39. Shaham Y, Stewart J (1995) Stress reinstates heroin-seeking in drug-free animals: an effect mimicking heroin, not withdrawal. Psychopharmacology 119:334-341
40. Shaham Y, Stewart J (1996) Effects of opioid and dopamine receptor antagonists on relapse induced by stress and re-exposure to heroin in rats. Psychopharmacology 125:385-391
41. Shaham Y, Funk D, Erb S, Brown TJ, Walker C-D, Stewart J (1997) Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats. J Neurosci 17:2605-2614
42. Shaliam Y, Erb S, Stewart J (2000a) Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res Rev 33:13-33
43. Shaham Y, Highfield D, Delfs J, Leung S, Stewart J (2000b) Clonidine blocks stress-induced reinstatement of heroin seeking in rats: an effect independent of locus coeruleus noradrenergic neurons. Eur J Neurosci 12:292-302
44. Shaham Y, Shalev U, Lu L, de Wit H, Stewart J (2003) The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology 168:3-20
45. Shalev U, Grimm JW, Shaham Y (2002) Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev 54:1-42
46. Sinha R (2001) How does stress increase risk of drug abuse and relapse? Psychopharmacology 158:343-359
47. Sinha R, Catapano D, O'Malley S (1999) Stress-induced craving and stress response in cocaine dependent individuals. Psychopharmacology 142:343-351
48. 3) as a novel target for antipsychotics. Biochem Pharmacol 43:659-666
49. Sorg BA, Kalivas PW (1993) Effects of cocaine and footshock stress on extracellular dopamine levels in the medial prefrontal cortex. Neuroscience 53:695-703
50. Stewart J (2000) Pathways to relapse: the neurobiology of drug- and stress-induced relapse to drug-taking. J Psychiatry Neurosci 25:125-136
51. Volkow ND, Fowler JS, Wang G-J (2002) Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies. Behav Pharmacol 13:355-366
52. 3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats. J Neurosci 22:9595-9603
53. Wallace BC (1992) Treating crack cocaine dependence: the critical role of relapse prevention. J Psychoact Drugs 24:213-222
54. Wicke K, Garcia-Ladona J (2001) The dopamine D3 receptor partial agonist, BP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors. Eur J Pharmacol 424:85-90
55. Winer BJ (1962) Statistical principles in experimental design. McGraw-Hill, New York
56. Wise RA (1996) Neurobiology of addiction. Curr Opin Neurobiol 6:243-251
57. Wood MD, Boyfield I, Nash DJ, Jewitt FR, Avenell KY, Riley GJ (2000) Evidence for antagonist activity of the dopamine D3 receptor partial agonist, BP 897, at human dopamine D3 receptor. Eur J Pharmacol 407:47-51